Cyclin: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 41: | Line 41: | ||
**[[2b9r]] – hCYCB1 (mutant)<br /> | **[[2b9r]] – hCYCB1 (mutant)<br /> | ||
**[[2jgz]] - hCYCB1 +CDK2 | **[[2jgz]] - hCYCB1 + CDK2<br /> | ||
**[[5hq0]], [[4yc3]], [[4y72]] – hCYCB1 + hCDK1 + CDK regulatory subunit 2<br /> | |||
**[[5lqf]] – hCYCB1 + hCDK1 + CDK regulatory subunit 2 + inhibitor<br /> | |||
*CYCC | *CYCC | ||
**[[3rgf]], [[4g6l]] – hCYCC + CDK8<br /> | **[[3rgf]], [[4g6l]] – hCYCC + CDK8<br /> | ||
**[[4f6s]], [[4f6u]], [[4f6w]], [[4f70]], [[4f7j]], [[4f7l]], [[4f7n]], [[4f7s]], [[5idp]], [[5idn]], [[5icp]], [[5i5z]], [[5hvy]], [[5hnb]], [[5hbj]], [[5hbh]], [[5hbe]], [[5fgk]], [[5cei]], [[5bnj]] – hCYCC + CDK8 + inhibitor<br /> | **[[4f6s]], [[4f6u]], [[4f6w]], [[4f70]], [[4f7j]], [[4f7l]], [[4f7n]], [[4f7s]], [[5idp]], [[5idn]], [[5icp]], [[5i5z]], [[5hvy]], [[5hnb]], [[5hbj]], [[5hbh]], [[5hbe]], [[5fgk]], [[5cei]], [[5bnj]], [[5xqx]], [[5xs2]] – hCYCC + CDK8 + inhibitor<br /> | ||
*CYCD | *CYCD | ||
**[[2w96]], [[2w99]], [[2w9f]], [[2w9z]] - hCYCD1 +CDK4 (mutant)<br /> | **[[2w96]], [[2w99]], [[2w9f]], [[2w9z]] - hCYCD1 +CDK4 (mutant)<br /> | ||
**[[3g33]] – hCYCD3 +CDK4 | **[[6ei2]] – hCYCD2 + HLA + microglobulin<br /> | ||
**[[3g33]] – hCYCD3 + CDK4 | |||
*CYCE | *CYCE | ||
**[[1w98]] – hCYCE1 +CDK2 T160P<br /> | **[[1w98]] – hCYCE1 + CDK2 T160P<br /> | ||
**[[5l2w]] – hCYCE1 + CDK2 + drug<br /> | **[[5l2w]] – hCYCE1 + CDK2 + drug<br /> | ||
Line 68: | Line 71: | ||
**[[4cxa]] - hCYCK + CDK12 T160P + AMPPNP<br /> | **[[4cxa]] - hCYCK + CDK12 T160P + AMPPNP<br /> | ||
**[[5efq]], [[4nst]] - hCYCK + CDK13 T160P + ADP<br /> | **[[5efq]], [[4nst]] - hCYCK + CDK13 T160P + ADP<br /> | ||
**[[4un0]], [[5acb]] - hCYCK +CDK12 T160P+inhibitor<br /> | **[[4un0]], [[5acb]], [[6b3e]] - hCYCK +CDK12 T160P + inhibitor<br /> | ||
*CYCT | *CYCT |